ADHD patients face rigid clinical guidelines and provider distrust when switching medications, forcing them to repeat failed, sub-therapeutic titration steps which wastes time, money, and compromises their daily functioning.
ADHD patients face rigid, non-individualized clinical guidelines, provider distrust, and administrative hurdles when transitioning medications, forcing them to repeat failed, sub-therapeutic titration steps which wastes time and money.
I finally understand the ire towards docs
Keep a journal of all this. It's super helpful to track your feelings, your side effects, you daily routine for a while.
commentFrustrating, but also I wouldn't necessarily get to bent out of shape. They are definitely trying to keep within guidelines to avoid trouble. I believe the supervisors response should have been more along the lines of hey, we got to make sure your case withstands and audit and we also want to make sure you are compliant. I'm not a doctor but I would've totally felt that a 40mg dose would've been good to start on since the 30mg was not so good. I was actually surprised that when I switched from Attentin the German health Ministry published a guide for 1-1 dosing to Elvanse. 10mg Attentin = 30mg Vyvanse. They even pointed out that 5mg Attentin might be necessary for a booster. I do however wish that they would allow compounding of these medications because since we are all unique I don't necessarily believe the one size fits all. Also, I want to stress, and you owe this to yourself. Keep a journal of all this. It's super helpful to track your feelings, your side effects, you daily routine for a while. This can help pinpoint areas to improve, like maybe you are wearing out faster because of a nutrition gap, or maybe you really need more water? I absolutely hate to say this, but supplements have helped me. Creatine, collagen peptides, protein all have done wonders. I have another condition that I'm not going to talk too much about, but it requires extensive blood tests every three months. I absolutely observed trends as I adjusted nutrition, exercise and supplements. Getting my main vitals in check to manage this other condition has also had a positive effect on my Vyvanse lasting through the core day and even beyond my work day. I also kept a fairly detailed log of things. And I can tell you there was a rough start with side effects they lasted three months, then I had crashes, they lasted about three months but now 9/10 months in and I'm doing great on 40mg. My point is, look more wholisticly and don't just focus on the medication. It's well worth going to your family doctor and having a good physical. Coordinate with them let them know it's not just curiosity that you really want to establish a baseline. Looking at everything from vitamin d to iron and if male look at testosterone. Then I'd get with them or a nutritionist or the googles lol and research the best way to adjust with nutrition and exercise. The key is don't fall for any gimmicks or vitamin solutions etc. But rather look at the science and studies.
Patients switching providers or medications who need to prove past therapeutic efficacy and daily wear-off patterns to secure appropriate personalized dosages.
Repeated complaints focus on clinical systems ignoring past medication history, forcing patients to repeat lower, failed dosages of standard commercial stimulants.
Unlike generic habit trackers, this is a clinical communication tool specifically engineered to build trust with cautious, skeptical psychiatric providers by using structured, objective patient data.
A HIPAA-compliant mobile logging and report-generation tool that lets patients systematically track daily ADHD symptoms, heart rate, medication wear-off, and side effects, compiling this telemetry into a structured, exportable clinical dossier. This PDF/dashboard presents clear pharmacological equivalence data and structured patient history that psychiatrists can confidently use to bypass redundant titration steps.
Users express high frustration with 'wasting time and money' on ineffective, redundant clinic visits. Paying a small fee to secure the correct prescription faster offers immediate financial and operational ROI.
“Prove your therapeutic baseline and skip failed titration steps in one click.”
A HIPAA-compliant mobile logging and report-generation tool that lets patients systematically track daily ADHD symptoms, heart rate, medication wear-off, and side effects, compiling this telemetry into a structured, exportable clinical dossier. This PDF/dashboard presents clear pharmacological equivalence data and structured patient history that psychiatrists can confidently use to bypass redundant titration steps.
Target highly active ADHD communities on Reddit (r/ADHD, r/Vyvanse, r/Adderall) and build partnerships with independent ADHD coaches/telehealth practitioners.
Psychiatrists may disregard patient-generated PDF reports as non-validated or overly subjective, refusing to bypass titration rules.
Storing daily psychological and physical health metrics requires absolute privacy and highly secure, compliant infrastructure.
Users with ADHD may struggle to maintain a daily logging habit unless the app experience is extremely low-friction and gamified.
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoThis opportunity scores well above the median for ideas surfaced by MonetScope, with a validation sub-score of 8/10 against 2 independently sourced evidence signals. A "strong" rating in this band typically means the pain signal is consistent and recurring across multiple discussions, but one of the three pillars (severity, willingness to pay, or competitor weakness) is somewhat softer than top-tier opportunities. Founders evaluating this should focus customer discovery on the softest pillar first — confirming the gap before committing engineering time to a build.
It sits at the intersection of "adhd", "analytics", "data-management", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. SaaS opportunities at this stage tend to win on the strength of their initial wedge — a single workflow that the target user runs every week, where the existing solution is either spreadsheets, a clunky incumbent feature, or a manual process they hate. The build cost is moderate; the distribution cost is everything. The MonetScope pipeline surfaces this category alongside other saas signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most saas opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.
